{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:05:54Z","timestamp":1791972354669,"version":"4.3.4"},"reference-count":84,"publisher":"American Diabetes Association","issue":"1","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:p>Digital health technology, especially digital and health applications (\u201capps\u201d), have been developing rapidly to help people manage their diabetes. Numerous health-related apps provided on smartphones and other wireless devices are available to support people with diabetes who need to adopt either lifestyle interventions or medication adjustments in response to glucose-monitoring data. However, regulations and guidelines have not caught up with the burgeoning field to standardize how mobile health apps are reviewed and monitored for patient safety and clinical validity. The available evidence on the safety and effectiveness of mobile health apps, especially for diabetes, remains limited. The European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) have therefore conducted a joint review of the current landscape of available diabetes digital health technology (only stand-alone diabetes apps, as opposed to those that are integral to a regulated medical device, such as insulin pumps, continuous glucose monitoring systems, and automated insulin delivery systems) and practices of regulatory authorities and organizations. We found that, across the U.S. and Europe, mobile apps intended to manage health and wellness are largely unregulated unless they meet the definition of medical devices for therapeutic and\/or diagnostic purposes. International organizations, including the International Medical Device Regulators Forum and the World Health Organization, have made strides in classifying different types of digital health technology and integrating digital health technology into the field of medical devices. As the diabetes digital health field continues to develop and become more fully integrated into everyday life, we wish to ensure that it is based on the best evidence for safety and efficacy. As a result, we bring to light several issues that the diabetes community, including regulatory authorities, policy makers, professional organizations, researchers, people with diabetes, and health care professionals, needs to address to ensure that diabetes health technology can meet its full potential. These issues range from inadequate evidence on app accuracy and clinical validity to lack of training provision, poor interoperability and standardization, and insufficient data security. We conclude with a series of recommended actions to resolve some of these shortcomings.<\/jats:p>","DOI":"10.2337\/dci19-0062","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T15:05:11Z","timestamp":1575558311000},"page":"250-260","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":282,"title":["Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group"],"prefix":"10.2337","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6549-0288","authenticated-orcid":false,"given":"G. Alexander","family":"Fleming","sequence":"first","affiliation":[{"name":"Kinexum, Harpers Ferry, WV"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Petrie","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-5584","authenticated-orcid":false,"given":"Richard M.","family":"Bergenstal","sequence":"additional","affiliation":[{"name":"International Diabetes Center at Park Nicollet, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W.","family":"Holl","sequence":"additional","affiliation":[{"name":"Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Peters","sequence":"additional","affiliation":[{"name":"Keck School of Medicine of the University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Science-Consulting in Diabetes GmbH, Neuss, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"2022031223534665000_B1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants","volume":"387","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2016","journal-title":"Lancet"},{"key":"2022031223534665000_B2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"2022031223534665000_B3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031223534665000_B4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"2022031223534665000_B5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1687-9856-2012-28","article-title":"New technologies for diabetes: a review of the present and the future","volume":"2012","author":"Ramchandani","year":"2012","journal-title":"Int J Pediatr Endocrinol"},{"key":"2022031223534665000_B6","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1089\/dia.2016.2506","article-title":"Using digital health technology to prevent and treat diabetes","volume":"18","author":"Kaufman","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"2022031223534665000_B7","unstructured":"World Health Organization. mHealth: New horizons for health through mobile technologies. Based on the findings of the second global survey on eHealth. Global Observatory for eHealth series \u2013 Volume 3. Geneva, WHO, 2011. Available from www.who.int\/goe\/publications\/goe_mhealth_web.pdf. Accessed 17 Sep 2018"},{"key":"2022031223534665000_B8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nbt.3284","article-title":"A regulatory framework emerges for digital medicine","volume":"33","author":"Elenko","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2022031223534665000_B9","unstructured":"Statista. Number of mHealth apps available in the Apple App Store from 1st quarter 2015 to 3rd quarter 2019. Available from www.statista.com\/statistics\/779910\/health-apps-available-ios-worldwide\/. Accessed 8 November 2019"},{"key":"2022031223534665000_B10","unstructured":"Pohl\u2008M. 325,000 mobile health apps available in 2017 \u2013 Android now the leading mHealth platform. 2017. Available from https:\/\/research2guidance.com\/325000-mobile-health-apps-available-in-2017\/. Accessed 3 December 2018"},{"key":"2022031223534665000_B11","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.2196\/jmir.2600","article-title":"Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis","volume":"15","author":"Mart\u00ednez-P\u00e9rez","year":"2013","journal-title":"J Med Internet Res"},{"key":"2022031223534665000_B12","first-page":"445","article-title":"AADE7 self-care behaviours","volume":"34","author":"AADE","year":"2008","journal-title":"Diabetes Educ"},{"key":"2022031223534665000_B13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fendo.2019.00135","article-title":"Popular diabetes apps and the impact of diabetes app use on self-care behaviour: a survey among the digital community of persons with diabetes on social media","volume":"10","author":"Kebede","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022031223534665000_B14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2337\/dc07-2137","article-title":"Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine","volume":"31","author":"Bergenstal","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031223534665000_B15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.amepre.2014.01.010","article-title":"Behavior change techniques in top-ranked mobile apps for physical activity","volume":"46","author":"Conroy","year":"2014","journal-title":"Am J Prev Med"},{"key":"2022031223534665000_B16","unstructured":"WellDoc. WellDoc Receives FDA 510(k) Clearance to Offer a Non-Prescription Version of BlueStar Digital Therapeutic for Type 2 Diabetes. 2017. Available from www.welldoc.com\/news\/welldoc-receives-fda-510k-clearance-to-offer-a-non-prescription-version-of-bluestar-digital-therapeutic-for-type-2-diabetes\/. Accessed 6 September 2019"},{"key":"2022031223534665000_B17","unstructured":"Brown\u2008A. Can Diabetes Apps Make Our Lives Easier?\u2008Lecture presented at the 78th Scientific Sessions of the American Diabetes Association, 23 June\u20082018, Orlando, FL. Available from https:\/\/diatribe.org\/Apps2018. Accessed 3 October 2019"},{"key":"2022031223534665000_B18","unstructured":"Cision PR Newswire. Hygieia receives 510(k) clearance from FDA for phone app that enhances company\u2019s d-Nav insulin guidance service. 2019. Available from www.prnewswire.com\/news-releases\/hygieia-receives-510k-clearance-from-fda-for-phone-app-that-enhances-companys-d-nav-insulin-guidance-service-300797091.html. Accessed 26 February 2019"},{"key":"2022031223534665000_B19","article-title":"FDA Perspective: mobile medical apps in diabetes management. Lecture presented at Diabetes Technology Meeting, 9 November","volume-title":"Bethesda, MD","author":"Schwartz","year":"2018"},{"key":"2022031223534665000_B20","unstructured":"Companion Medical. InPen. Available from www.companionmedical.com\/InPen\/. Accessed 7 December 2018"},{"key":"2022031223534665000_B21","unstructured":"Dexcom. Dexcom Clarity. Available from https:\/\/clarity.dexcom.com. Accessed 13 February 2019"},{"key":"2022031223534665000_B22","unstructured":"Medtronic. Sugar.IQ Diabetes Assistant | Exclusive to Guardian Connect CGM. Available from www.medtronicdiabetes.com\/products\/sugar.iq-diabetes-assistant. Accessed 13 February 2019"},{"key":"2022031223534665000_B23","unstructured":"U.S. Food and Drug Administration. What is the pancreas? What is an artificial pancreas device system?\u2008Available from www.fda.gov\/medical-devices\/artificial-pancreas-device-system\/what-pancreas-what-artificial-pancreas-device-system. Accessed 12 June 2019"},{"key":"2022031223534665000_B24","unstructured":"diaTribe. The FDA Approves Medtronic\u2019s MiniMed 670G Hybrid Closed Loop System. Available from https:\/\/diatribe.org\/fda-approval-medtronic-minimed-670g-hybrid-closed-loop-system. Accessed 3 October 2019"},{"key":"2022031223534665000_B25","unstructured":"Bankmycell.com. How many phones are there in the world? 1 billion more mobile connections than people worldwide. Available from www.bankmycell.com\/blog\/how-many-phones-are-in-the-world#targetText=According%20to%20Statista%2C%20there%20is,population%20have%20a%20smartphone%20today. Accessed 6 September 2019"},{"key":"2022031223534665000_B26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10865-016-9765-3","article-title":"What do we know about mobile applications for diabetes self-management? A review of reviews","volume":"39","author":"Hood","year":"2016","journal-title":"J Behav Med"},{"key":"2022031223534665000_B27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1932296815576956","article-title":"Integrating visual dietary documentation in mobile-phone-based self-management application for adolescents with type 1 diabetes","volume":"9","author":"Fr\u00f8island","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2022031223534665000_B28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/amiajnl-2012-001510","article-title":"Comparison of traditional versus mobile app self-monitoring of physical activity and dietary intake among overweight adults participating in an mHealth weight loss program","volume":"20","author":"Turner-McGrievy","year":"2013","journal-title":"J Am Med Inform Assoc"},{"key":"2022031223534665000_B29","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1530\/EJE-14-0441","article-title":"Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"172","author":"Huang","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2022031223534665000_B30","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.2196\/jmir.2968","article-title":"Mobile applications for diabetics: a systematic review and expert-based usability evaluation considering the special requirements of diabetes patients age 50 years or older","volume":"16","author":"Arnhold","year":"2014","journal-title":"J Med Internet Res"},{"key":"2022031223534665000_B31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ecl.2016.06.001","article-title":"Evidence-based mobile medical applications in diabetes","volume":"45","author":"Drincic","year":"2016","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022031223534665000_B32","unstructured":"U.S. Food and Drug Administration. Policy for Device Software Functions and Mobile Medical Applications. 2019. Available from www.fda.gov\/media\/80958\/download. Accessed 8 November 2019"},{"key":"2022031223534665000_B33","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/1932296818771200","article-title":"Finding real value from digital diabetes health: is digital health dead or in need of resuscitation?","volume":"12","author":"Kerr","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"2022031223534665000_B34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2016.8708","article-title":"Need for a national evaluation system for health technology","volume":"316","author":"Shuren","year":"2016","journal-title":"JAMA"},{"key":"2022031223534665000_B35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/pedi.12731","article-title":"ISPAD clinical practice consensus guidelines 2018: diabetes technologies","volume":"19","author":"Sherr","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"2022031223534665000_B36","unstructured":"European Commission. Guidance document medical devices - scope, field of application, definition - qualification and classification of stand alone software - MEDDEV 2.1\/6. Updated July 2016. Available from http:\/\/ec.europa.eu\/DocsRoom\/documents\/17921\/attachments\/1\/translations. Accessed 19 September 2018"},{"key":"2022031223534665000_B37","unstructured":"European Commission. Transformation of health and care in the digital single market. Available from https:\/\/ec.europa.eu\/digital-single-market\/en\/european-policy-ehealth. Accessed 19 September 2018"},{"key":"2022031223534665000_B38","unstructured":"European Commission. EU health policy. Available from https:\/\/ec.europa.eu\/health\/policies\/overview_en. Accessed 19 September 2018"},{"key":"2022031223534665000_B39","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMhle1113918","article-title":"Regulation of medical devices in the United States and European Union","volume":"366","author":"Kramer","year":"2012","journal-title":"N Engl J Med"},{"key":"2022031223534665000_B40","unstructured":"European Commission. The \u201cBlue Guide\u201d on the implementation of EU products rules\u20082016. Available from https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:52016XC0726(02)&rid=7. Accessed 22 September 2018"},{"key":"2022031223534665000_B41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","article-title":"Drugs and devices: comparison of European and U.S. approval processes","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2022031223534665000_B42","unstructured":"European Commission. Medical Devices Regulatory Framework. Available from https:\/\/ec.europa.eu\/growth\/sectors\/medical-devices\/regulatory-framework_en. Accessed 13 February 2019"},{"key":"2022031223534665000_B43","unstructured":"L\u00e4kemedelsverket Medical Products Agency. Medical Information Systems \u2013 guidance for qualification and classification of standalone software with a medical purpose. Uppsala, Sweden, L\u00e4kemedelsverket Medical Products Agency. Available from https:\/\/lakemedelsverket.se\/upload\/eng-mpa-se\/vagledningar_eng\/medical-information-system-guideline.pdf. Accessed 20 September 2018"},{"key":"2022031223534665000_B44","unstructured":"European Network of Research Ethics Committee. The Act on Medical Devices (Medical Devices Act) (Medizinproduktegesetz \u2013 MPG) (especially \u00a7\u00a719-24). Available from www.eurecnet.org\/legislation\/germany.html. Accessed 20 September 2018"},{"key":"2022031223534665000_B45","unstructured":"U.S. Food and Drug Administration. Mobile medical applications. Available from www.fda.gov\/medical-devices\/digital-health\/mobile-medical-applications. Accessed 6 September 2019"},{"key":"2022031223534665000_B46","unstructured":"U.S. Food and Drug Administration. 21st Century Cures Act. Available from www.fda.gov\/regulatoryinformation\/lawsenforcedbyfda\/significantamendmentstothefdcact\/21stcenturycuresact\/default.htm. Accessed 19 September 2018"},{"key":"2022031223534665000_B47","unstructured":"U.S. Food and Drug Administration. Digital Health. Available from www.fda.gov\/MedicalDevices\/DigitalHealth\/default.htm. Accessed 19 September 2018"},{"key":"2022031223534665000_B48","unstructured":"U.S. Food and Drug Administration. National Evaluation System for health Technology (NEST). Available from www.fda.gov\/aboutfda\/centersoffices\/officeofmedicalproductsandtobacco\/cdrh\/cdrhreports\/ucm301912.htm. Accessed 13 February 2019"},{"key":"2022031223534665000_B49","article-title":"Changing Times at the FDA","volume-title":"Lecture presented at Diabetes Technology Meeting","author":"Shuren"},{"key":"2022031223534665000_B50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nbt.3495","article-title":"Digital medicine\u2019s march on chronic disease","volume":"34","author":"Kvedar","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2022031223534665000_B51","unstructured":"U.S. Food and Drug Administration. Submitting documents using real-world data and real-world evidence to FDA for drugs and biologics: guidance for industry. 2019. Available from www.fda.gov\/media\/124795\/download. Accessed 13 June 2019"},{"key":"2022031223534665000_B52","unstructured":"U.S. Food & Drug Administration. Use of real-world evidence to support regulatory decision-making for medical devices: guidance for industry and food and drug administration staff. 31 August 2017. Available from www.fda.gov\/media\/99447\/download. Accessed 13 June 2019"},{"key":"2022031223534665000_B53","unstructured":"Brown\u2008A, Carracher\u2008A, Kurian\u2008M, et al. JPM 2019: January 7-10; San Francisco, CA; Day #2 Highlights \u2013 Draft. Updated Jan 8, 2019. Available from www.closeconcerns.com\/knowledgebase\/r\/5a490a4b. Accessed 23 January 2019"},{"key":"2022031223534665000_B54","unstructured":"U.S. Food and Drug Administration. Digital Health Software Precertification (Pre-Cert) Program. Available from www.fda.gov\/MedicalDevices\/DigitalHealth\/DigitalHealthPreCertProgram\/default.htm. Accessed 13 June 2019"},{"key":"2022031223534665000_B55","unstructured":"IMDRF. International Medical Device Regulators Forum. Available from www.imdrf.org. Accessed 20 September 2018"},{"key":"2022031223534665000_B56","unstructured":"IMDRF SaMD Working Group. Final Document: \u201cSoftware as a Medical Device\u201d: Possible Framework for Risk Categorization and Corresponding Considerations. 2014. Available from www.imdrf.org\/docs\/imdrf\/final\/technical\/imdrf-tech-140918-samd-framework-risk-categorization-141013.pdf. Accessed 13 February 2019"},{"key":"2022031223534665000_B57","unstructured":"IMDRF SaMD Working Group. Proposed Document: Software as a Medical Device (SaMD): Application of Quality Management System. 2015. Available from www.imdrf.org\/docs\/imdrf\/final\/technical\/imdrf-tech-151002-samd-qms.pdf. Accessed 3 October 2019"},{"key":"2022031223534665000_B58","unstructured":"U.S. Food and Drug Administration. Software as a Medical Device (SAMD): Clinical Evaluation. Guidance for Industry and Food and Drug Administration Staff. 2017. Available from https:\/\/www.fda.gov\/media\/100714\/download. Accessed 3 October 2019"},{"key":"2022031223534665000_B59","unstructured":"World Health Organization. Classification of digital health interventions v1.0: A shared language to describe the uses of digital technology for health. 2018. Available from https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260480\/WHO-RHR-18.06-eng.pdf;jsessionid=CE0199154B170C471D487632C549A142?sequence=1. Accessed 20 September 2018"},{"key":"2022031223534665000_B60","unstructured":"National Health Service. How we access apps. Available from https:\/\/apps.beta.nhs.uk\/how-we-assess-apps\/. Accessed 24 January 2019"},{"key":"2022031223534665000_B61","unstructured":"National Health Service. Diabetes-related apps. Available from https:\/\/apps.beta.nhs.uk\/category\/diabetes\/. Accessed 24 January 2019"},{"key":"2022031223534665000_B62","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.2196\/jmir.5692","article-title":"Can mobile phone apps influence people\u2019s health behavior change? An evidence review","volume":"18","author":"Zhao","year":"2016","journal-title":"J Med Internet Res"},{"key":"2022031223534665000_B63","doi-asserted-by":"crossref","DOI":"10.23970\/AHRQEPCTB31","article-title":"Mobile Applications for Self-Management of Diabetes","author":"Veazie","year":"2018"},{"key":"2022031223534665000_B64","first-page":"356","article-title":"Mobile devices and apps for health care professionals: uses and benefits","volume":"39","author":"Ventola","year":"2014","journal-title":"P&T"},{"key":"2022031223534665000_B65","first-page":"48","article-title":"Part 1: simple definition and calculation of accuracy, sensitivity and specificity","volume":"3","author":"Baratloo","year":"2015","journal-title":"Emergency (Tehran)"},{"key":"2022031223534665000_B66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pec.2012.07.016","article-title":"Smart phone apps: smart patients, steer clear","volume":"89","author":"Hogan","year":"2012","journal-title":"Patient Educ Couns"},{"key":"2022031223534665000_B67","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.2337\/dc17-0853","article-title":"Mobile apps for the management of diabetes","volume":"40","author":"Chavez","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031223534665000_B68","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2196\/jmir.3062","article-title":"Evaluation of the accuracy of smartphone medical calculation apps","volume":"16","author":"Bierbrier","year":"2014","journal-title":"J Med Internet Res"},{"key":"2022031223534665000_B69","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jama.2019.1644","article-title":"Decision support and alerts of apps for self-management of blood glucose for type 2 diabetes","volume":"321","author":"Lum","year":"2019","journal-title":"JAMA"},{"key":"2022031223534665000_B70","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fendo.2017.00318","article-title":"Content analysis of mobile health applications on diabetes mellitus","volume":"8","author":"Izahar","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022031223534665000_B71","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/diaspect.26.4.211","article-title":"Evaluation and evolution of diabetes mobile applications: key factors for health care professionals seeking to guide patients","volume":"26","author":"Ristau","year":"2013","journal-title":"Diabetes Spectr"},{"key":"2022031223534665000_B72","unstructured":"Apple. Health. Available from www.apple.com\/ios\/health\/. Accessed 3 October 2019"},{"key":"2022031223534665000_B73","unstructured":"Tidepool. Tidepool Mobile. Available from https:\/\/tidepool.org\/users#mobile. Accessed 13 February 2019"},{"key":"2022031223534665000_B74","unstructured":"Google. Google Fit. Available from www.google.com\/fit\/. Accessed 13 February 2019"},{"key":"2022031223534665000_B75","volume-title":"National Diabetes Statistics Report, 2017: Estimates of Diabetes and Its Burden in the United States","author":"Department of Health and Human Services, Centers for Disease Control and Prevention","year":"2017"},{"key":"2022031223534665000_B76","article-title":"Advances in BGM Logbooks and Apps","volume-title":"Lecture presented at Diabetes Technology Meeting","author":"Ahn"},{"key":"2022031223534665000_B77","unstructured":"Rose\u2008KJ, K\u00f6nig\u2008M, Wiesbauer\u2008F. Evaluating success for behavorial change in diabetes via mHealth and gamification: mySugr\u2019s keys to retention and patient engagement. Poster presented at Advanced Technologies and Treatments for Diabetes, 27 February\u20133 March\u20082013, Paris, France. Available from https:\/\/assets.mysugr.com\/website\/mysugr.com-wordpress\/uploads\/2017\/03\/attd-2013-poster.pdf. Accessed 3 October 2019"},{"key":"2022031223534665000_B78","unstructured":"Medtronic. Medtronic launches patient engagement program that leverages gamification to help motivate and engage patients living with diabetes. 2018. Available from http:\/\/newsroom.medtronic.com\/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2363121. Accessed 24 January 2018"},{"key":"2022031223534665000_B79","unstructured":"Levine\u2008B, Brown\u2008A, Close\u2008K. UnitedHealthcare adds Apple Watch to Motion physical activity incentives program; people with diabetes 40% more likely to enroll in Motion \u2013 November 21, 2018. Available from www.closeconcerns.com\/knowledgebase\/r\/96d89360. Accessed 24 January 2019"},{"key":"2022031223534665000_B80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jbi.2017.05.011","article-title":"A systematic review of gamification in e-Health","volume":"71","author":"Sardi","year":"2017","journal-title":"J Biomed Inform"},{"key":"2022031223534665000_B81","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.2015.19426","article-title":"Privacy policies of android diabetes apps and sharing of health information","volume":"315","author":"Blenner","year":"2016","journal-title":"JAMA"},{"key":"2022031223534665000_B82","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/1932296815583334","article-title":"Cybersecurity for connected diabetes devices","volume":"9","author":"Klonoff","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"2022031223534665000_B83","unstructured":"Diabetes Technology Society. Standard for Wireless Diabetes Device Security (DTSec). 2017. Available from www.diabetestechnology.org\/dtsec\/DTSec%20Standard.pdf. Accessed 16 November 2018"},{"key":"2022031223534665000_B84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12916-018-1211-7","article-title":"How can clinicians, specialty societies and others evaluate and improve the quality of apps for patient use?","volume":"16","author":"Wyatt","year":"2018","journal-title":"BMC Med"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/1\/250\/530012\/dci190062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/1\/250\/530012\/dci190062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T21:51:35Z","timestamp":1647121895000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/1\/250\/35864\/Diabetes-Digital-App-Technology-Benefits"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12,12]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci19-0062","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}